# Novel Approach to Increase EPA and DHA Levels

> **NCT07304921** · PHASE1 · COMPLETED · sponsor: **Riga Stradins University** · enrollment: 48 (actual)

## Conditions studied

- Lipid Metabolism
- Omega-3 Polyunsaturated Fatty Acids
- Supplementation

## Interventions

- **DRUG:** Meldonium + PUFA
- **DIETARY_SUPPLEMENT:** PUFA + meldonium
- **DIETARY_SUPPLEMENT:** PUFA supplementation only

## Key facts

- **NCT ID:** NCT07304921
- **Lead sponsor:** Riga Stradins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-06
- **Primary completion:** 2023-06-06
- **Final completion:** 2023-06-06
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07304921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07304921, "Novel Approach to Increase EPA and DHA Levels". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07304921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*